Delivery Order SPE2DR25D2007-SPE2DR26FM76S
Award Date 4/1/26
Potential Completion Date 4/22/26
Potential Value $32K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $29,195.26 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Pomalyst 4 mg capsules (21-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 2, 2026, for Pomalyst 2 mg capsules with a ceiling value of $14,552.44 under a firm fixed-price structure. The order is callable against AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026, which supplies pharmaceutical products and medical commodities to support military healthcare programs globally. Place...
- The Defense Logistics Agency awarded a delivery order valued at $27,703.52 to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Pomalyst (pomalidomide) 4 mg capsules in a 21-count package. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of October 20, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $14,597.62 to AmerisourceBergen Drug Corp for the supply of Pomalyst 4 mg capsules (21-count units) on November 13, 2025, with an ultimate completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pomalyst 4 mg capsules (21-count packages) on December 2, 2025, with a ceiling value of $43,792.86 and completion date of December 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $13,851.76 delivery order to AmerisourceBergen Drug Corp for Pomalyst 4 mg capsules (21-count) on November 12, 2025, with completion targeted for December 4, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made on a competitive, non-set-aside basis, and performance will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Pomalyst (pomalidomide) 1 mg capsules in quantities of 100 units. This firm fixed price delivery order, valued at $114,147.61, is set to be completed by July 14, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting the company's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Pomalyst 1 mg capsules (100-count units) with a ceiling value of $292,457.73. This firm fixed price delivery order, with an ultimate completion date of May 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was...
- The Defense Logistics Agency awarded a $13,851.75 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Pomalyst 4 mg capsules (21-count units). This is a firm fixed-price, non-set-aside contract with performance scheduled for completion by August 29, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide POMALYST 2 MG CAPSULE 21S, a pharmaceutical product. The delivery order has a ceiling value of $12,287.90 and a firm fixed price pricing type. It was awarded on March 26, 2024 with an ultimate completion date of April 16, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp, the prime contractor, is a...